![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at 11th Annual Needham Healthcare Conference
02 avr. 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., April 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 11th Annual Needham Healthcare Conference at 10:00 AM ET on...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Receives Complete Response Letter from Food and Drug Administration for Northera(TM) (droxidopa) Capsules
28 mars 2012 18h39 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 28, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at Roth 24th Annual OC Growth Stock Conference
12 mars 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 12, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Keith Schmidt, VP Marketing and Sales, is scheduled to present at the Roth 24th...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at Cowen and Company 32nd Annual Healthcare Conference
07 mars 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Cowen and...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Reports Fourth Quarter and Full Year 2011 Results
06 mars 2012 16h05 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2011 and will host a...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
02 mars 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it plans to release fourth quarter and full year 2011 results after the market...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa) for the Treatment of Symptomatic Neurogenic OH
23 févr. 2012 17h05 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Discuss NORTHERA(TM) (droxidopa) NDA for the Treatment of Symptomatic Neurogenic OH at FDA Advisory Committee Meeting on February 23
21 févr. 2012 08h14 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) will meet with the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
16 févr. 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Leerink Swann...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics CEO to Review NORTHERA(TM) NDA and Provide an Update on Upcoming Advisory Committee Meeting During Presentation at BIO CEO
13 févr. 2012 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that during a presentation at the 14th Annual BIO CEO and Investor Conference...